Federal Trade Commission et al v. Vyera Pharmaceuticals, LLC et al

  1. April 28, 2021

    Rollback Of Restitution Power Leaves FTC Cases In Limbo

    The U.S. Supreme Court's ruling last week in AMG Capital v. FTC all but stripped the Federal Trade Commission of its ability to recoup money from lawbreakers in federal court and the agency's pending cases are sure to feel the impact.

  2. March 30, 2021

    No Jury, No Forfeiture For 'Pharma Bro' Shkreli In FTC Case

    Martin Shkreli dropped demands for a jury trial on Tuesday and, in exchange, seven U.S. states agreed not to seek civil penalties or forfeitures in a Federal Trade Commission-led lawsuit, which claims the former biopharma executive and his company Vyera blocked rivals from developing generic versions of the anti-parasite drug Daraprim.

  3. January 25, 2021

    'Pharma Bro' Shkreli Can't Have FTC Prison Call Transcripts

    The Federal Trade Commission does not have to provide Martin Shkreli with transcripts of phone calls he made from prison, a New York federal judge ruled Monday, saying the agency already shared the audio recordings with the infamous ex-pharmaceutical executive.

  4. January 08, 2021

    Shkreli Can't Pause Suit Pending Prison Release, Judge Says

    A New York federal court on Friday denied "Pharma Bro" Martin Shkreli's request to stay discovery in the Federal Trade Commission and states' lawsuit against him until he is released from prison in 2023, stating that the 37-year-old had not shown "good cause" to stay the proceedings.

  5. December 22, 2020

    Shkreli Can't Delay January FTC Deposition, NY Judge Says

    Martin Shkreli can't push back his deposition set for next month in the Federal Trade Commission's monopolization case against him and his company, a New York federal judge ruled Tuesday, rejecting the incarcerated "pharma bro's" request to delay it until late February.

  6. November 30, 2020

    Judge Won't Quickly Pause Discovery In Shkreli's FTC Case

    A New York federal judge said Monday she won't immediately grant the request of incarcerated "pharma bro" Martin Shkreli to pause discovery in a monopolization case the Federal Trade Commission brought against him earlier this year.

  7. November 12, 2020

    Shkreli's Objections To FTC Prison Comms Access Tossed

    A New York federal judge overruled objections from incarcerated "pharma bro" Martin Shkreli regarding the Federal Trade Commission's access to his prison telephone communications, in the FTC's legal challenge against Shkreli on charges of monopolizing sales of the anti-parasitic drug Daraprim.

  8. October 29, 2020

    FTC Says Shkreli Can't Relitigate Authority Challenge

    The Federal Trade Commission and several state attorneys general continue to argue that incarcerated "Pharma Bro" Martin Shkreli should be blocked from arguing that they lack the authority to sue him on charges of monopolizing sales of the anti-parasitic drug Daraprim.

  9. October 22, 2020

    Shkreli Says FTC Can't Nix Challenge To Authority

    Martin Shkreli urged a New York federal judge Wednesday not to let the Federal Trade Commission and several state attorneys general block him from arguing they lack the authority to sue the incarcerated "Pharma Bro" for monopolizing sales of the anti-parasitic drug Daraprim.

  10. August 20, 2020

    Shkreli's Prison Comms Get Partial Protection From FTC

    A New York federal judge on Thursday ordered the Federal Trade Commission to "make reasonable efforts" not to look at Martin Shkreli jailhouse communications with his attorneys but otherwise permitted a look at other conversations the incarcerated "pharma bro" may have had about monopolizing sales of the antiparasitic drug Daraprim.